Anika Therapeutics, Inc. (ANIK)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 409.12M |
| Enterprise value | 365.29M |
| Trailing P/E | 43.00 |
| Forward P/E | 24.63 |
| PEG ratio (5-yr expected) | 2.46 |
| Price/sales (ttm) | 2.43 |
| Price/book (mrq) | 1.93 |
| Enterprise value/revenue | 2.19 |
| Enterprise value/EBITDA | -32.52 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.75 |
| 52-week change 3 | 6.20% |
| S&P500 52-week change 3 | 22.38% |
| 52-week high 3 | 28.19 |
| 52-week low 3 | 16.54 |
| 50-day moving average 3 | 25.60 |
| 200-day moving average 3 | 22.14 |
Share statistics
| Avg vol (3-month) 3 | 79.63k |
| Avg vol (10-day) 3 | 47.42k |
| Shares outstanding 5 | 14.83M |
| Implied shares outstanding 6 | 14.83M |
| Float 8 | 10.7M |
| % held by insiders 1 | 2.97% |
| % held by institutions 1 | 93.05% |
| Shares short (15 Apr 2024) 4 | 811.11k |
| Short ratio (15 Apr 2024) 4 | 10.26 |
| Short % of float (15 Apr 2024) 4 | 7.73% |
| Short % of shares outstanding (15 Apr 2024) 4 | 5.46% |
| Shares short (prior month 15 Mar 2024) 4 | 766.09k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -49.60% |
| Operating margin (ttm) | 56.80% |
Management effectiveness
| Return on assets (ttm) | -2.36% |
| Return on equity (ttm) | -33.21% |
Income statement
| Revenue (ttm) | 166.66M |
| Revenue per share (ttm) | 11.37 |
| Quarterly revenue growth (yoy) | 8.50% |
| Gross profit (ttm) | N/A |
| EBITDA | 2.52M |
| Net income avi to common (ttm) | -82.67M |
| Diluted EPS (ttm) | -5.64 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 72.87M |
| Total cash per share (mrq) | 4.97 |
| Total debt (mrq) | 29.04M |
| Total debt/equity (mrq) | 13.68% |
| Current ratio (mrq) | 5.26 |
| Book value per share (mrq) | 14.48 |
Cash flow statement
| Operating cash flow (ttm) | -1.79M |
| Levered free cash flow (ttm) | 12.58M |
© 2024 Yahoo. All rights reserved.